Introduction
Modifications at the cytosine bases 5meC (5′-methylcytosine), 5hmC (5′-hydroxymethylcytosine), 5fC (5′-formylcytosine), and 5caC (5′-carboxycytosine) that are dynamically regulated in cells are involved in the process of gene transcription. Some level of cytosine is de novo methylated in early development (Hata et al., 2002; Silva et al., 2011; Li and O'Neill, 2013 ) and this pattern is mostly maintained in adult organisms (Feng et al., 2010; Illingworth et al., 2010; Maunakea et al., 2010) . However, some levels of change in cytosine methylation are facultative under certain environmental conditions in normal cells (Christensen et al., 2009; Ronn et al., 2013; Ricceri et al., 2014) . Alterations in DNA methylation at the gene and/ or genome level can also be associated with cancer. There are some applications using DNA demethylating agent(s) to reverse increased DNA methylation in cancer, and some approaches include a combined treatment of these agents with chemotherapeutic drugs (Oki et al., 2007) . Anticancer drugs are able to damage the DNA of cancer cells but can have a side effect on the DNA of healthy cells as well (Chen et al., 2007) . This is one of the important handicaps of chemotherapeutic therapy of cancer.
We have previously shown that DNA damage induced by chemotherapeutic doxorubicin in healthy (noncancerous) mouse fibroblasts is associated with an increased level of global 5meC (Çelik et al., 2015) ; however, the active demethylation mechanism suggests a removal of DNA methylation after DNA damage (Santos et al., 2013) . On the other hand, another remarkable question is how global levels of DNA methylation and of its further metabolites change in healthy fibroblasts after treatment with doxorubicin at doses that do not induce DNA damage. Therefore, in this study, we aimed to analyze the response of cells to doxorubicin without DNA damage in terms of global levels of cytosine modifications.
Technologies, Carlsbad, CA, USA; #10099-141), 1% (v/v) 1× MEM nonessential amino acids solution (Invitrogen, #11140-050) , 50 U/mL penicillin (Sigma-Aldrich; St. Louis, MO, USA; #P3032), and 50 µg/mL streptomycin (Sigma, #S6501) at 37 °C with 5% CO 2 in air. Cells were grown as proliferative (1-day) or quiescent (24-h serumstarved confluent) cultures.
Doxorubicin treatment
The genotoxic agent used was doxorubicin, which is a DNA-intercalating chemotherapeutic drug inducing DNA damage such double-strand breaks in DNA molecules during active cell proliferation. We previously found that doxorubicin at 50 nM induced DNA damage (Çelik et al., 2015) and so in this study proliferative cells were treated with doxorubicin (Sigma, #D1515) at lower doses of 0.125 and 2.5 nM in complete media for 24 h at 37 °C with 5% CO 2 in air. The control cells were untreated (0 nM).
Room light treatment
Quiescent cells were treated with room light for 12 min. The cells were kept in HEPES-buffered media (Invitrogen, #12430) at 37 °C during the exposure. The treated cells were then incubated for a further 1 h at 37 °C with 5% CO 2 in air. The control cells were dark-treated by covering the culture flask with foil.
Cell viability and cell cycle analysis
After treatment, the cells were washed with 1× DPBS (Invitrogen; #14190-144) (Ca 2 + , Mg 2 + free, prewarmed to 37 °C before use) and detached with 0.25% trypsin-EDTA (Invitrogen; #25200-56) for up to 5 min. Trypsin was inactivated with an equal volume of complete media and removed with 4 min of centrifugation at 400 × g. Cells were washed in 1× PBS and were split for two assays. For cell viability, cells were incubated in a 0.4% trypan blue solution (Sigma, #T8154) for 10 min at room temperature (RT). Cells excluded or stained with trypan blue were counted using a hemocytometer. For the cell cycle analysis, cells were incubated with propidium iodide (Sigma; #P4170) in 2% triton-x/PBS (v/v) at a final concentration of 50 mM for 30 min at RT in the dark. DNA mass in the G1, S and G2 phases was analyzed by using the fluorescence channel-2 (FL2-A) of a flow cytometry instrument (BD FACSCalibr, BDIS, San Jose, CA, USA). The analysis of the DNA mass over the cycle is based on the DNA content in the cells. Cell populations were analyzed using BD CellQuestTM Pro (BD FACSCalibr). Dot plots and histograms were made using Flowing software version 2.3.3 (Turku Centre for Biotechnology, Finland). 2.5. DNA damage assessment DNA damage was assessed as previously described (Çelik et al., 2015) by immunostaining of (γ)-H2A.X (phosphoS139). For this, MEFs were washed in 1× PBS and fixed with 2% (w/v) PFA (Sigma, #P6148) for 30 min at RT after treatment. The cells were then permeabilized with 2% PFA containing 0.3% (v/v) tween-20 (Sigma, #P7949) and 0.2% (v/v) triton-x (Bio-Rad Laboratories Inc., Hercules, CA, USA, #161-0407) for 30 min at RT. Cells were washed in 1× PBS (w/v) (Sigma, # D5773) for 30 min followed by blocking with 30% (v/v) goat serum (Sigma, #G9023) in 2 mg/mL BSA in PBS with 0.05% triton-x (w/v) (BSA, from Sigma, #A1470) for 3 h at RT. Next, the cells were washed in 1× PBS for 30 min at RT. The cells were incubated in primary antibodies (1:250) rabbit polyclonal antigamma (γ)-H2A.X (phosphoS139) (Abcam, UK; #ab2893) to detect DNA damage, or alternatively a nonimmune rabbit IgG (Sigma, #I5006) in 2 mg/mL BSA in PBS with 0.05% (v/v) triton-x at 4 °C overnight. Then the cells were washed in 1× PBS for 30 min and incubated with a fluorescein-conjugated secondary antibody, (FITC, fluorescein isothiocyanate) (1:200) (Sigma, #F1262) in 2 mg/mL BSA in PBS with 0.05% triton-x (w/v) for 1 h at RT in the dark. Cells were then washed in 1× PBS for 30 min and mounted with 1× PBS. Slides were assessed using an epifluorescence microscope, Eclipse 80i (Nikon Instruments Inc., USA). Images were captured by camera [CoolSnap of (Photometrics, AZ, USA)]. The staining level of the phosphorylated H2AX (γ-H2AX) was analyzed using Image-Pro Plus version 5.0 (Media Cybernetics, Rockville, MD, USA). The total staining (sum value) of γ-H2AX in each nucleus was measured, and the level of staining is based on optical density (a.u. = arbitrary units). 2.6. Genomic DNA isolation Genomic DNA was isolated using a Wizard Genomic DNA purification kit (Promega, #A1120) according to the manufacturer's instructions. Briefly, detached cells were washed with 1× PBS followed by treatments with nuclei lysis solution, RNase solution, and protein precipitation solution. The RNA-free and protein-free pellet was then treated with isopropanol, washed with ethanol, and rehydrated for 1 h. Isolated DNA samples were kept in DNA rehydration solution at 4 °C. To test the DNA quality, concentrations and purities of the isolated DNA were measured using a NanoDrop 2000 UV-Vis spectrometer (Thermo Fisher), and DNA integrity was tested using agarose gel electrophoresis.
ELISA-based colorimetric detection of global 5meC, 5hmC, and 5fC
For global 5meC and 5hmC quantification 100 ng of DNA from each sample was used, and for global 5fC quantification 300 ng of DNA from each sample was used. Global 5meC, 5hmC, and 5fC were quantified using a MethylFlash DNA methylation quantification kit (Epigentek, Farmingdale, NY, USA, #P1034), a MethylFlash DNA hydroxymethylation quantification kit (Epigentek, #P1036), and a MethylFlash 5-formylcytosine quantification kit (Epigentek, #P1041), respectively, according to the manufacturer's protocols. These protocols basically include (1) DNA binding to strip wells with high DNA binding affinity, (2) treatment with a capture antibody and a detection antibody, (3) color development, and (4) measurement of absorbance at 450 nm. The amounts of 5meC, 5hmC, and 5fC are proportional to the optical density (OD) measured. A standard curve was made for calculation of 5meC%, 5hmC%, and 5fC%. The standard control for a 5meC assay contains 50% methylated cytosine and the standard control for a 5hmC assay contains 20% hydroxymethylated cytosine. For the 5fC assay, the standard control was normalized to have 100% 5fC. Linear regressions were generated as follows:
5meC Values for 5meC%, 5hmC%, and 5fC% were calculated using the following formulas with a negative control (NC): 5meC% = (sample OD -NC OD) / (slope × 2) × 100% 5hmC% = (sample OD -NC OD) / (slope × 5) × 100% 5fC% = (sample OD -NC OD) / slope × 100% 2.8. Statistical analysis Statistical analyses were performed using SPSS version 17.0. The percentages of cells in cell-cycle checkpoints, the percentages of viable cells, and the percentages of 5meC, 5hmC, and 5fC were arcsine-transformed and compared using a univariate analysis of variance (UNIANOVA) test. The staining level of phosphorylated H2AX (γ-H2AX) was also analyzed with UNIANOVA. The differences between groups were determined with a post-hoc test. Each independent experiment was performed as three independent replicates. Coefficients of variation within and between assays are provided in supplement 1 and the raw data are included in supplement 2.
Results
Genomic DNA samples were isolated from cells after treatment and global 5meC, 5hmC, and 5fC were quantified using kits. Standard curves for calculating the levels of 5meC, 5hmC, and 5fC were obtained ( Figures 1A-1C ). Proliferating cells were treated with doxorubicin (0, 0.125, or 2.5 nM) for 24 h, and analyzed by (i) microscopy of the γ-H2AX immunostaining, (ii) observation of arrested cell proportions at checkpoints of the cell cycle, and (iii) trypan blue staining. Although the number of cells stained with γ-H2AX increased after each dose of doxorubicin (P < 0.0001) (Figure 2A ), the staining levels of γ-H2AX were not different compared to the untreated cells (P > 0.05) (Figures 2B-2C ). The cell cycle analyses showed no significant arrest of cells at checkpoints after doxorubicin ( Figure 2D ), and the proportion of viable cells Standard curves of (A) 5meC, (B) 5hmC, and (C) 5fC for ELISA-based quantification. For the 5meC and 5hmC assays, the standard controls contained 50% methylated cytosine and 20% hydroxymethylcytosine, respectively. For the 5fC assay, the standard control is normalized to have 100% 5fC. OD = optical density.
was not reduced after doxorubicin (data not shown). These results show that the doses of doxorubicin examined did not induce significant DNA damage and were nontoxic as aimed. We then investigated the levels of cytosine modification marks. The level of 5meC increased in cells after the 0.125 nM dose of doxorubicin (P < 0.05), but The cell cycle analysis shows no change in arrested cell number at the G2/M checkpoint. (E) The global quantification of 5meC, 5hmC, and 5fC is shown with post-hoc comparisons. **** = P < 0.0001. Experiments were performed with three independent replicates. Bar graphs show ± standard mean of the error. a.u = arbitrary units, scale bar = 10 µm. interestingly was not different from the untreated control cells after the higher dose of 2.5 nM ( Figure 2E ). The level of 5hmC was constant after each dose (P > 0.05). The level of 5fC significantly decreased, in some cases reaching zero, after the 2.5 nM doxorubicin treatment (P < 0.05), but was not different after the lower dose of 0.125 nM ( Figure 2E ). After each treatment, the level of 5meC was much higher than both 5hmC (P < 0.0001) and 5fC (P < 0.0001). No difference was found between the levels of 5hmC and 5fC (P > 0.05) within both the untreated cells and treated (0.125 nM) cells ( Figure 2E ). However, a significant difference between 5hmC and 5fC was observed after the 2.5 nM doxorubicin treatment (P < 0.01). These results show that the cytosines are mostly methylated, but less hydroxymethylated or formylated regardless of the doxorubicin treatment and 5fC is highly sensitive to doxorubicin treatment (2.5 nM). To test whether the sensitivity of 5fC only depends on the nature of a genotoxic agent, we next tested the levels of cytosine modification in cells after a treatment known to be nongenotoxic, namely room light. For this, confluent cells were incubated under room light for 12 min followed by 1 h of incubation. As expected, room light did not induce any DNA damage as the number of nuclei stained with γ-H2AX ( Figure 3A ) and the staining level of γ-H2AX (Figures 3Ba and 3Bb) were not different (P > 0.05). There was no significant number of arrested cells at the checkpoints after exposure to room light compared to the control cells (P > 0.05) ( Figure 3C ). Cell viability also did not alter after room light exposure (data not shown). The level of 5meC was similar in both the control and treated cells (P > 0.05), and was much higher than the levels of 5hmC (P < 0.0001) and 5fC (P < 0.0001) ( Figure 3D) . Interestingly, the level of 5fC was significantly greater than that of 5hmC in the control cells (P < 0.05). 5hmC tend to increase after room light but the increase was insignificant (P > 0.05); in contrast, the level of 5fC unexpectedly and significantly decreased after the room light treatment (P < 0.05) ( Figure 3D ).
Discussion
This study showed for the first time that changes in the level of 5fC can correlate to in vitro treatment of normal cells with a chemotherapeutic agent at a dose that does not induce DNA damage. It suggests that the response of normal cells to these kinds of agents can include alterations of 5fC even if there is no significant DNA damage. 5meC tends to change after doxorubicin treatment but this is not the case for 5hmC. Interestingly, the level of 5hmC is resistant to change after both genotoxic and nongenotoxic treatments. These results can give a hint about the conditions induced by chemotherapeutic agents that affect cytosine modifications in healthy cells. To the best of our knowledge, the effects of chemotherapeutic agents on the pattern of cytosine modifications in healthy cells have not been explored before. This appears important, as the current problem with chemotherapeutics is their damage of healthy cells as well as cancerous cells.
We have previously shown that a toxic dose (50 nM) of doxorubicin for 24 h induced DNA damage in mouse fibroblasts and was associated with an increased global level of methylation (Çelik et al., 2015) . Changes in DNA methylation (and in other cytosine modifications) after DNA damage are suggested by the proposed mechanism of active demethylation (Cortellino et al., 2011; Santos et al., 2013) . DNA methylation is newly patterned during early development (Hata et al., 2002; Silva et al., 2011; Li and O'Neill, 2013) , and this pattern is typically preserved in adult organisms (Feng et al., 2010; Illingworth et al., 2010; Maunakea et al., 2010) . However, the degree of DNA methylation varies depending on the environmental conditions (Christensen et al., 2009; Ronn et al., 2013; Ricceri et al., 2014) . Variations in DNA methylation can therefore occur in normal cells, depending on one's lifestyle, as well as in diseases such cancer.
The findings suggest that (i) 5meC is the most abundant cytosine modification compared to the other cytosine modifications, as previously shown in the nervous system, kidney, bladder, heart, muscle, lung, and liver Munzel et al., 2010) ; (ii) 5hmC is a rather stable modification; and (iii) 5fC is highly sensitive to nongenotoxic treatment in embryonic fibroblasts as well as to treatment with the genotoxic agent doxorubicin. The level of 5hmC is known to be a stable mark at high levels in the adult mouse brain (Kinney et al., 2011; Bachman et al., 2014) , but relatively very low in embryonic fibroblasts (Kinney et al., 2011) . 5fC has been defined as a rare modification found in many tissues (Booth et al., 2014; Bachman et al., 2015) , but we have observed that the level of 5fC is higher than that of 5hmC in fibroblasts. Although 5fC is rare, it can exist in specific sites with levels comparable to 5meC and 5hmC (Booth et al., 2014) . In our study, changes in the global level of 5fC did not show any relationship with changes in the global level of either 5meC or 5hmC in any treatment. No correlation was detected between 5fC and either 5meC or 5hmC (Bachman et al., 2015) . Interestingly the level of 5fC changed after a nongenotoxic treatment of room light but the level of 5meC was more resistant to change after treatment with room light. Although neither treatment induced DNA damage, the level of 5meC may alter after doxorubicin treatment, suggesting it has sensitivity to genotoxic agents. We could not perform the experiment for 5caC cytosine modification since a kit for colorimetric quantification of 5caC does not exist yet. Although this limits the study, the results can be further extended by the The global quantification of 5meC, 5hmC, and 5fC is shown. * = P < 0.05, *** = P < 0.001, and **** = P < 0.0001. Experiments were performed with three independent replicates. Bar graphs show ± standard mean of the error. a.u = arbitrary units, and scale bar = 10 µm. investigation of each cytosine modification in normal cells using alternative methods such immunofluorescence and comparing to different cancer cell lines after treatment with chemotherapeutic and/or demethylating agents.
In conclusion, our results indicate that 5fC is more susceptible to genotoxic and nongenotoxic conditions than 5meC and 5hmC. The decrease in the level of 5fC is not associated with a significant level of DNA damage after the examination of different environmental conditions. These findings are expected to improve the understanding of how cytosine modifications vary in cellular response to such widely used chemotherapy. 
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